FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

7491000087102: BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
137691000087117 BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
95621000087111 BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
95631000087113 Tdap-IPV BOOSTRIX-POLIO GSK en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
97001000087117 dcaT-VPI BOOSTRIX-POLIO GSK fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Adult vaccine product containing only tetanus + diphtheria low dose + acellular pertussis low dose + inactivated human poliovirus antigens (medicinal product) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Inactivated whole Human poliovirus serotype 3 Saukett strain antigen true Inferred relationship Some 5
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Adult vaccine product containing diphtheria antigen in low dose (medicinal product) false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Antigen of inactivated whole Human poliovirus serotype 2 MEF1 strain (substance) true Inferred relationship Some 4
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Adult vaccine product containing acellular pertussis antigen in low dose (medicinal product) false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has supplier GlaxoSmithKline Inc. (supplier) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Plays role Active immunity stimulant role (role) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Vaccine product containing Clostridium tetani toxoid antigen (medicinal product) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has ingredient characteristic (attribute) faible dose false Inferred relationship Some 1
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Tetanus toxoid true Inferred relationship Some 6
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Antigen of acellular Bordetella pertussis (substance) true Inferred relationship Some 2
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Diphtheria toxoid true Inferred relationship Some 1
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Antigen of inactivated whole Human poliovirus serotype 1 Mahoney strain (substance) true Inferred relationship Some 3
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has product characteristic Adulthood (qualifier value) false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product) false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has ingredient characteristic (attribute) faible dose false Inferred relationship Some 2
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Count of base of active ingredient quatre false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Corynebacterium diphtheriae toxoid antigen-containing vaccine product true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Count of active ingredient six false Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has target population Adult population (qualifier value) true Inferred relationship Some
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has ingredient qualitative strength faible dose true Inferred relationship Some 2
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has ingredient qualitative strength faible dose true Inferred relationship Some 1
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Pertussis vaccine (substance) false Inferred relationship Some 1
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) vaccin inactivé contre la poliomyélite false Inferred relationship Some 4
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Vaccin tétanos false Inferred relationship Some 2
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Diphtheria vaccine (substance) false Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start